Natural killer cells in carcinomatous pleural effusionsAtsushi Uchida; Michael Micksche · 1981

In vitro augmentation of natural killing activity by OK-432Atsushi Uchida; Michael Micksche · 1981

Suppressor cells for natural killer activity in carcinomatous pleural effusions of cancer patientsAtsushi Uchida; Michael Micksche · 1981

Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patientsEtsuro Yanagawa; Atsushi Uchida; Michael Moore; Michael Micksche · 1985

Reactivity to autologous non-T-cells and suppressor function of human autologous rosettesAtsushi Uchida; Michael Micksche · 1981

Concanavalin A-inducible suppressor cells in pleural effusions and peripheral blood of cancer patientsAtsushi Uchida; Michael Micksche · 1981

Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patientsEtsuro Yanagawa; Atsushi Uchida; Eva M. Kokoschka; Michael Micksche · 1984

Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cellsAtsushi Uchida; Michael Micksche · 1983

Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.Kattan, J; Culine, S; Terrier-Lacombe, M J; Theodore, C; Droz, J P · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1993

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Markman, M; Rothman, R; Hakes, T; Reichman, B; Hoskins, W; Rubin, S; Jones, W; Almadrones, L; Lewis, J L · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1991

Intrathecal chemotherapy for treatment of overt meningeal leukemia: comparison between intraventricular and traditional intralumbar routeIacoangeli, M; Roselli, R; Pagano, L; Leone, G; Marra, R; Pompucci, a; Trignani, R; Scerrati, M · Annals of oncology: official journal of the European Society for Medical Oncology / ESMO · 1995

Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin.Hansen, S W; Olsen, N; Rossing, N; Rorth, M · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1990

A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patients.Sosman, J a; Fisher, S G; Kefer, C; Fisher, R I; Ellis, T M · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1994

The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial.Mazzocato, C; Buclin, T; Rapin, C H · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1999

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.Middleton, M R; Grob, J J; Aaronson, N; Fierlbeck, G; Tilgen, W; Seiter, S; Gore, M; Aamdal, S; Cebon, J; Coates, a; Dreno, B; Henz, M; Schadendorf, D; Kapp, a; Weiss, J; Fraass, U; Statkevich, P; Muller, M; Thatcher, N · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2000

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.Catimel, G; Verweij, J; Mattijssen, V; Hanauske, a; Piccart, M; Wanders, J; Franklin, H; {Le Bail}, N; Clavel, M; Kaye, S B · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1994